Suppliers / Fareva La Vallee

Fareva La Vallee

France Updated 9 July 2026

Fareva La Vallee is an API manufacturer based in France. It holds one active US drug master file and one valid CEP. Its GMP standing is certified by ANSM (FR) and US FDA. Its most recent recorded inspection, by US FDA, closed on 6 October 2023 as VAI.

1
active US DMFs
1
valid CEPs
4
registered plants 1 with an FDA FEI number
0
filings across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
4 of 4 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 6 October 2023 VAI US FDA
  • 1 June 2018 VAI US FDA
  • 15 May 2014 NAI US FDA
  • 27 May 2011 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
France, France 3003121602
Saint-Germain-Laprade, France Not on file
SAINT GERMAIN LAPRADE, France Not on file
St Germain Laprade, France Not on file

What they file, and where

Molecule Regulators Docs
Timolol EDQM, US FDA 2

Also appears on these molecule pages

Timolol API

Filings and GMP by regulator

Regulator Filings GMP certificates
ANSM (FR) None 10
US FDA None 1

Questions about Fareva La Vallee

Does Fareva La Vallee hold a US DMF or a CEP?
Fareva La Vallee holds 1 active US drug master file and 1 valid CEP. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Is Fareva La Vallee FDA-registered?
One site operated by Fareva La Vallee carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Fareva La Vallee's last inspection go?
The most recent inspection on record closed on 6 October 2023 as VAI (Voluntary Action Indicated: issues were found but did not warrant regulatory action). 4 inspections are on file.
Where does Fareva La Vallee manufacture?
4 registered sites are on record, in France (France, Saint-germain-laprade and Saint Germain Laprade among others). Every site is listed on this page with the register it came from.
What does Fareva La Vallee make?
1 molecule is on record against Fareva La Vallee, including Timolol. Each links through to that molecule's full manufacturer list.
Which regulators recognise Fareva La Vallee's GMP?
Current GMP certificates are on record from ANSM (FR) and US FDA. GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Fareva La Vallee comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 6 October 2023.

Comparable suppliers

Olon shares 1 molecule Micro Labs shares 1 molecule Centaur Pharmaceuticals shares 1 molecule Excella Gmbh shares 1 molecule FDC Limited shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates